DVHGF (Devonian Health Group) 3-Year Dividend Growth Rate : 0.00% (As of Oct. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Devonian Health Group 3-Year Dividend Growth Rate?

Devonian Health Group's Dividends per Share for the three months ended in Oct. 2024 was $0.00.

The historical rank and industry rank for Devonian Health Group's 3-Year Dividend Growth Rate or its related term are showing as below:

DVHGF's 3-Year Dividend Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 10.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Devonian Health Group's Dividend Payout Ratio for the three months ended in Oct. 2024 was 0.00. As of today, Devonian Health Group's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Devonian Health Group's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Devonian Health Group's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devonian Health Group's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's 3-Year Dividend Growth Rate falls into.

Devonian Health Group 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Devonian Health Group (OTCPK:DVHGF) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Devonian Health Group's Dividend Payout Ratio for the quarter that ended in Oct. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Oct. 2024 )	/	EPS without NRI (Q: Oct. 2024 )
	=	0	/	-0.001
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devonian Health Group 3-Year Dividend Growth Rate Related Terms>

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (OTCPK:DVHGF) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

GSD:Canada

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

From GuruFocus

Devonian Announces the Closing of a $315,000 Private Placement and an Additional Loan of $500,000

By GlobeNewswire GlobeNewswire • 08-22-2019